Celularity Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Celularity Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Celularity Inc - Ordinary Shares - Class A
Rating: 1.85858325
Author: Trendlyne DVM scores

about

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adher...

3.24 -0.01 (-0.31%)

37.93% Fall from 52W High

36,124

XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.8 / 100

Technically Moderately Bullish

65.5 / 100

No estimates available

Celularity Inc - Ordinary ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celularity Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adher...

37.93% Fall from 52W High

SWOT Analysis

Celularity Inc - Ordinary ... Live Price Chart